Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of UV-4B in Healthy Subjects
NCT02061358Phase 1Completed
- Sponsor
- Emergent BioSolutions
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of UV-4B in dengue fever (8 cohorts), sponsored by Emergent BioSolutions. Primary endpoints: Subjects With Treatment-emergent Adverse Events at Day 9, Subjects With Serious Adverse Events at Day 9 and 3 more. Started Jul 2014; status: completed.
02
Drugs
UV-4B
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT02061358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061358.